Rapid Micro Biosystems, Inc.
RPID
$2.46
$0.187.90%
Weiss Ratings | RPID - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | RPID - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Fair | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | RPID - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.70 | |||
Price History | RPID - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -9.56% | |||
30-Day Total Return | 28.80% | |||
60-Day Total Return | 145.93% | |||
90-Day Total Return | 127.78% | |||
Year to Date Total Return | 150.23% | |||
1-Year Total Return | 146.59% | |||
2-Year Total Return | 112.07% | |||
3-Year Total Return | -59.00% | |||
5-Year Total Return | -- | |||
52-Week High % Change | -43.62% | |||
52-Week Low % Change | 293.10% | |||
Price | RPID - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $4.04 | |||
52-Week Low Price | $0.58 | |||
52-Week Low Price (Date) | Jul 03, 2024 | |||
52-Week High Price (Date) | Feb 19, 2025 | |||
Valuation | RPID - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 98.58M | |||
Enterprise Value | 53.53M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -1.08 | |||
Earnings Per Share Growth | -11.74% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 3.56 | |||
Price/Book (Q) | 1.30 | |||
Enterprise Value/Revenue (TTM) | 1.91 | |||
Price | $2.46 | |||
Enterprise Value/EBITDA (TTM) | -1.14 | |||
Enterprise Value/EBIT | -1.07 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | RPID - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 43.77M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | RPID - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 978 349 3200 | |||
Address | 1001 Pawtucket Boulevard West Lowell, MA 01854 | |||
Website | www.rapidmicrobio.com | |||
Country | United States | |||
Year Founded | 2006 | |||
Profitability | RPID - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -177.95% | |||
Profit Margin | -167.15% | |||
Management Effectiveness | RPID - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -25.83% | |||
Return on Equity | -- | |||
Income Statement | RPID - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 28.05M | |||
Total Revenue (TTM) | 28.05M | |||
Revenue Per Share | $0.64 | |||
Gross Profit (TTM) | -109.00K | |||
EBITDA (TTM) | -46.96M | |||
EBIT (TTM) | -49.92M | |||
Net Income (TTM) | -46.89M | |||
Net Income Avl. to Common (TTM) | -46.89M | |||
Total Revenue Growth (Q YOY) | 29.68% | |||
Earnings Growth (Q YOY) | 13.48% | |||
EPS Diluted (TTM) | -1.08 | |||
EPS Diluted Growth (Q YOY) | 14.75% | |||
Balance Sheet | RPID - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 51.22M | |||
Cash Per Share (Q) | $1.17 | |||
Total Current Assets (Q) | 80.92M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 75.35M | |||
Current Ratio (Q) | 4.607 | |||
Book Value Per Share (Q) | $1.75 | |||
Total Assets (Q) | 98.17M | |||
Total Current Liabilities (Q) | 17.57M | |||
Total Debt (Q) | 6.17M | |||
Total Liabilities (Q) | 22.82M | |||
Total Common Equity (Q) | 75.35M | |||
Cash Flow | RPID - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 36.66M | |||
Cash from Financing (TTM) | 203.00K | |||
Net Change in Cash (TTM) | -7.29M | |||
Levered Free Cash Flow (TTM) | -28.83M | |||
Cash from Operations (TTM) | -44.15M | |||